Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L
Wednesday 25th October 2023
3:00 PM BST
A panel discussion with:
- Ed Kivell, Life Sciences lead EMEA/APAC, AlphaSense
- Matthias Mullenbeck, SVP, Head Global Business Development & Alliance Management, Merck
- Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics
- Martin-Immanuel Bittner, Co-Founder and CEO, Arctoris
- Marko Kuisma, Partner, Innovestor
In the rapidly evolving landscape of biopharmaceuticals, the integration of artificial intelligence (AI) has become pivotal. Join us as we explore the remarkable impact of AI on various facets of the biopharma industry, with a particular focus on its transformative role in Business Development and Licensing (BD&L).
Discover how AI-powered solutions are reshaping the way biopharma companies identify opportunities, enhance decision-making, and drive innovation.
Book your free place at the webinar to find out more!
.png?width=847&height=476&name=Unlocking%20the%20Future%20The%20Growing%20Significance%20of%20AI%20in%20Biopharma%20and%20BD%26L%20(4).png)
